Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2009-12-01Clinical Trial Update: Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment [NA]
A clinical trial update focusing on detecting EGFR mutations in malignant pleural effusion from lung cancer patients and the establishment o…
-
CLINICAL_TRIALS research · 2009-11-25Clinical Trial Update: Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update describes salvage therapy with sunitinib, docetaxel, and platinum for metastatic or unresectable non-small c…
-
CLINICAL_TRIALS research · 2009-10-28Clinical Trial Update: Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial is evaluating airway stents to relieve restricted airways in centrally located non-small cell lung cancer; the curr…
-
CLINICAL_TRIALS research · 2009-10-27Clinical Trial Update: The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer
Clinical trial update examining the role of PET imaging during erlotinib treatment for non-small cell lung cancer, with the trial status lis…
-
CLINICAL_TRIALS research · 2009-10-06Clinical Trial Update: EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)
A clinical trial update discusses using endobronchial ultrasound-guided TBNA for molecular diagnostics of mediastinal lymph nodes in non-sma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-09-03Clinical Trial Update: Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Update on a Phase 2 trial of NRX 194204 in patients with advanced non-small cell lung cancer; the current study status is unknown.
-
CLINICAL_TRIALS research · 2009-08-25Clinical Trial Update: Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluating the combination of sorafenib and erlotinib in patients with stage IIIB or stage IV non-small cell lung c…
-
CLINICAL_TRIALS research · 2009-07-13Clinical Trial Update: Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating hypofractionated intensity-modulated chemoradiotherapy for locally advanced stage III non-small cell lun…
-
CLINICAL_TRIALS research · 2009-06-18Clinical Trial Update: Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer [Phase 2]
This Clinical Trials update reports a Phase 2 study evaluating pemetrexed plus oxaliplatin as adjuvant chemotherapy after surgical resection…
-
CLINICAL_TRIALS research · 2009-05-25Clinical Trial Update: Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen [Phase 2]
This document provides a Phase 2 trial update on the combination of erlotinib and docetaxel in patients with locally advanced or metastatic …
-
CLINICAL_TRIALS research · 2009-05-21Clinical Trial Update: Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 2]
A Phase 2 clinical trial update investigating biweekly gemcitabine and docetaxel as first-line therapy for advanced non-small cell lung canc…
-
CLINICAL_TRIALS research · 2009-05-19Clinical Trial Update: PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)
A clinical trial update describing the pharmacoeconomic assessment of IRESSA (gefitinib) for Non-Small Cell Lung Cancer.
-
CLINICAL_TRIALS research · 2009-05-18Clinical Trial Update: Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma [NA]
This clinical trial update describes a study investigating EGFR mutation–guided second-line therapy for patients with advanced lung adenocar…
-
CLINICAL_TRIALS research · 2009-04-22Clinical Trial Update: Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 2]
This document reports a Phase 2 clinical trial evaluating the use of nitroglycerin alongside chemotherapy and radiotherapy in patients with …
-
CLINICAL_TRIALS research · 2009-03-03Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial update exploring radiolabeled monoclonal antibody therapy for relapsed or refractory non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2009-02-18Clinical Trial Update: Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung Cancer
Clinical trial update describing the use of vibration response imaging (VRI) to aid preoperative management in patients with non-small cell …
-
CLINICAL_TRIALS research · 2009-02-09Clinical Trial Update: Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial evaluates paclitaxel and carboplatin with radiation therapy, with or without adjuvant paclitaxel and carboplatin, f…
-
CLINICAL_TRIALS research · 2009-02-09Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating the combination of chemotherapy and radiation therapy for patients w…
-
CLINICAL_TRIALS research · 2008-12-31Clinical Trial Update: Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib
The study investigates whether EGFR gene mutations in non-small cell lung cancer predict response to the EGFR inhibitor erlotinib. The trial…
-
CLINICAL_TRIALS research · 2008-10-21Clinical Trial Update: Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy [Phase 1]
Phase I study evaluating gefitinib (Iressa) in combination with CRT/IMRT in Chinese patients with IIIB/IV non-small cell lung cancer after p…
-
CLINICAL_TRIALS research · 2008-08-04Clinical Trial Update: Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma. [Phase 2]
Protocol for a Phase 2 study evaluating primary fractionated stereotactic body radiation therapy for early-stage (T1-T3N0) non-small cell lu…
-
CLINICAL_TRIALS research · 2008-07-30Clinical Trial Update: Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling [Phase 2]
This is a Phase 2 pilot study evaluating whether gene expression profiling can predict chemotherapy response in advanced non-small cell lung…
-
CLINICAL_TRIALS research · 2008-07-24Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
This clinical trial update describes a Phase 2 study of gemcitabine plus docetaxel in patients with inoperable stage IIIB or stage IV non-sm…
-
CLINICAL_TRIALS research · 2008-07-24Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy in patients with stage IIIB or stage IV non-small cell lung cancer; the st…
-
CLINICAL_TRIALS research · 2008-06-04Clinical Trial Update: Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis [NA]
An update on a clinical trial validating coregistered CT-PET imaging for measuring tumor volume and atelectasis in patients with operable no…